Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

A594V

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Human cytomegalovirus (HCMV) is the most frequent cause of opportunistic viral infection following transplantation. Viral factors… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 2
2017
2017
Abstract The aim of this study was to characterize Human Cytomegalovirus (HCMV) drug resistance mutations in UL97 and UL54 genes… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 1
2016
2016
Background Human cytomegalovirus (HCMV) infections are a major cause of morbidity and mortality among immunocompromised patients… Expand
  • figure 2
  • figure 1
  • table 1
2015
2015
The emergence of ganciclovir (GCV) resistance during the treatment of human cytomegalovirus (HCMV) infection is a serious… Expand
  • figure 1
  • figure 2
2014
2014
BACKGROUND Antiviral resistance development is a serious complication of human cytomegalovirus virostatic therapy caused by… Expand
2013
2013
ABSTRACT Human cytomegalovirus (HCMV) resistance to antivirals is a major problem in immunocompromised patients. Drug resistance… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2013
2013
We characterised by pyrosequencing, the dynamics of cytomegalovirus populations harbouring mutations A594V in gene UL97 and A834P… Expand
  • figure 1
  • table 1
2009
2009
OBJECTIVES Valganciclovir is a well established drug for the management of cytomegalovirus (CMV) infection in haematopoietic stem… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2008
2008
Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell… Expand
2006
2006
Transplant recipients that have not been previously exposed to the cytomegalovirus (CMV) are highly susceptible to viral diseases… Expand